| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 告达亭苷元; Caudatin | CFN99007 | 38395-02-7 | C28H42O7 = 490.6 | 20mg | QQ客服：3257982914 |
| Mannioside A; Mannioside A | CFN99055 | 1038922-95-0 | C39H62O13 = 738.9 | 5mg | QQ客服：2056216494 |
| 8-羟基毛地黄毒素; 8-Hydroxydigitoxigenin | CFN99069 | 1049674-06-7 | C23H34O5 = 390.5 | 5mg | QQ客服：2159513211 |
| 豆甾-4-烯-3-酮; Sitostenone | CFN99073 | 1058-61-3 | C29H48O = 412.7 | 5mg | QQ客服：2159513211 |
| 7alpha-羟基谷甾醇3-O-beta-D-葡萄糖苷; Ikshusterol 3-O-glucoside | CFN99217 | 112137-81-2 | C35H60O7 = 592.9 | 5mg | QQ客服：3257982914 |
| 豆甾烷-3,6-二醇; Stigmastane-3,6-diol | CFN99220 | 112244-29-8 | C29H52O2 = 432.7 | 5mg | QQ客服：2056216494 |
| 豆甾-4-烯-3,6-二醇; Stigmast-4-ene-3,6-diol | CFN99234 | 113626-76-9 | C29H50O2 = 430.7 | 5mg | QQ客服：1413575084 |
| 黄夹竹桃乙糖苷; Thevebioside | CFN99245 | 114586-47-9 | C36H56O13 = 696.8 | 5mg | QQ客服：2056216494 |
| 17alpha-黄夹竹桃乙糖苷; 17alpha-Thevebioside | CFN99246 | 114613-59-1 | C36H56O13 = 696.8 | 5mg | QQ客服：3257982914 |
| 赤桐甾醇葡糖苷; Clerosterol glucoside | CFN99351 | 123621-00-1 | C35H58O6 = 574.8 | 5mg | QQ客服：3257982914 |
| 6-O-甲基啤酒甾醇; 6-O-Methylcerevisterol | CFN99372 | 126060-09-1 | C29H48O3 = 444.7 | 5mg | QQ客服：215959384 |
| Daturataturin A; Daturataturin A | CFN99414 | 133360-51-7 | C34H48O10 = 616.8 | 5mg | QQ客服：2159513211 |
| 松甾酮A; Ponasterone A | CFN99419 | 13408-56-5 | C27H44O6 = 464.6 | 5mg | QQ客服：1457312923 |
| 过氧麦角甾醇 3-O-beta-D-吡喃葡萄糖苷; Ergosterol peroxide glucoside | CFN99458 | 140447-22-9 | C34H54O8 = 590.8 | 5mg | QQ客服：2159513211 |
| 薯蓣皂苷元; Diosgenin | CFN99515 | 512-04-9 | C27H42O3 = 414.63 | 20mg | QQ客服：2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)